{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:49:21Z","timestamp":1788184161458,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacadv.2025.102208","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:42:17Z","timestamp":1759347737000},"page":"102208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P1","title":["Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality"],"prefix":"10.1016","volume":"4","author":[{"given":"Dimitrios","family":"Terentes-Printzios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4589-7822","authenticated-orcid":false,"given":"Maria Eleni","family":"Koilakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Antonopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Kasiakogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Themistoklis","family":"Katsimichas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Lazaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Tsampras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freideriki Eleni","family":"Kourti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Ioakeimidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Vlachopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2025.102208_bib1","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/biomedicines10081906","article-title":"The journey of human transthyretin: synthesis, structure stability, and catabolism","volume":"10","author":"Sanguinetti","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jacadv.2025.102208_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1515\/CCLM.2007.051","article-title":"Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition","volume":"45","author":"Myron Johnson","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jacadv.2025.102208_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2025.102208_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hjc.2023.09.019","article-title":"Transthyretin amyloidosis cardiomyopathy in Greece: clinical insights from the national referral center","volume":"79","author":"Bampatsias","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib5","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1007\/s00018-021-03899-3","article-title":"The role of transthyretin in cell biology: impact on human pathophysiology","volume":"78","author":"Magalh\u00e3es","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jacadv.2025.102208_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40120-020-00217-0","article-title":"A narrative review of the role of transthyretin in health and disease","volume":"9","author":"Liz","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.jacadv.2025.102208_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jchf.2025.03.017","article-title":"Current landscape of therapies for transthyretin amyloid cardiomyopathy","volume":"13","author":"Griffin","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamacardio.2024.4102","article-title":"Transthyretin tetramer destabilization and increased mortality in the general population","volume":"10","author":"Christoffersen","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/CLEP.S475408","article-title":"Serum prealbumin levels and risks of adverse clinical outcomes after ischemic stroke","volume":"16","author":"Shi","year":"2024","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.26599\/1671-5411.2024.04.003","article-title":"Association of prealbumin with short-term and long-term outcomes in patients with acute ST-segment elevation myocardial infarction","volume":"21","author":"Tan","year":"2024","journal-title":"J Geriatric Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib11","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1038\/s41467-024-50231-1","article-title":"Determinants of transthyretin levels and their association with adverse clinical outcomes among UK biobank participants","volume":"15","author":"Shetty","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jacadv.2025.102208_bib12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/ajkd.2001.29256","article-title":"Serum prealbumin predicts survival in hemodialysis and peritoneal dialysis: 10 years of prospective observation","volume":"38","author":"Mittman","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacadv.2025.102208_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jjcc.2018.08.003","article-title":"Prognostic implications of prealbumin level on admission in patients with acute heart failure referred to a cardiac intensive care unit","volume":"73","author":"Akashi","year":"2019","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib14","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.3390\/nu14183848","article-title":"Nutritional predictors of mortality after 10 years of Follow-Up in patients with chronic kidney disease at a multidisciplinary unit of advanced chronic kidney disease","volume":"14","author":"Barril","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jacadv.2025.102208_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jpen.2470","article-title":"Association between prealbumin, all-cause mortality, and response to nutrition treatment in patients at nutrition risk: secondary analysis of a randomized controlled trial","volume":"47","author":"Bretscher","year":"2023","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jacadv.2025.102208_bib16","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1016\/j.ijcard.2013.04.039","article-title":"Prealbumin improves death risk prediction of BNP-added Seattle heart failure model: results from a pilot study in elderly chronic heart failure patients","volume":"168","author":"Cabassi","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib17","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/j.1523-1755.2005.00751.x","article-title":"Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients","volume":"68","author":"Chertow","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacadv.2025.102208_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.amjcard.2017.08.004","article-title":"Preoperative prealbumin level as a predictor of outcomes in patients who underwent left ventricular assist device implantation","volume":"120","author":"Critsinelis","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejim.2017.05.009","article-title":"Impact of prealbumin on mortality and hospital readmission in patients with acute heart failure","volume":"43","author":"Franco","year":"2017","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacadv.2025.102208_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0272-6386(12)70189-0","article-title":"Prealbumin and Lipoprotein(a) in hemodialysis: relationships with patient and vascular access survival","volume":"22","author":"Goldwasser","year":"1993","journal-title":"Am J Kidney Diseases"},{"key":"10.1016\/j.jacadv.2025.102208_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamacardio.2020.5969","article-title":"Association of low plasma transthyretin concentration with risk of heart failure in the general population","volume":"6","author":"Greve","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004000","article-title":"Use of serum transthyretin as a prognostic indicator and predictor of outcome in cardiac amyloid disease associated with wild-type transthyretin","volume":"11","author":"Hanson","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/17843286.2020.1737779","article-title":"Malnutrition risk and its association with adverse outcomes in a Belgian cohort of community-dwelling adults aged 80 years and over","volume":"76","author":"Hegend\u00f6rfer","year":"2021","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jacadv.2025.102208_bib24","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc12-0455","article-title":"Transthyretin predicts cardiovascular outcome in hemodialysis patients with type 2 diabetes","volume":"35","author":"Henze","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacadv.2025.102208_bib25","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1161\/ATVBAHA.113.301273","article-title":"Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy","volume":"33","author":"Hornstrup","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacadv.2025.102208_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276159","article-title":"Albumin to prealbumin ratio in peritoneal dialysis patients: clinical implication and outcome prediction","volume":"17","author":"Huang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jacadv.2025.102208_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/1744-9987.13768","article-title":"Range of serum transthyretin levels in hemodialysis patients at a high risk of 1-year mortality: a retrospective cohort study","volume":"26","author":"Kumagai","year":"2022","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jacadv.2025.102208_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.krcp.2016.06.002","article-title":"Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis","volume":"35","author":"Lee","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"10.1016\/j.jacadv.2025.102208_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000526354","article-title":"Serum prealbumin levels on admission as a prognostic marker in stroke patients treated with mechanical thrombectomy","volume":"12","author":"L\u00f3pez","year":"2022","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.jacadv.2025.102208_bib30","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1136\/heartjnl-2014-305747","article-title":"Low prealbumin is strongly associated with adverse outcome in heart failure","volume":"100","author":"Louren\u00e7o","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jacadv.2025.102208_bib31","first-page":"848","article-title":"Influence of pre-albumin and N-terminal pro-brain natriuretic peptide on the prognosis of elderly patients with chronic heart failure","volume":"29","author":"Lu","year":"2015","journal-title":"J Chin Pract Diagn Ther"},{"key":"10.1016\/j.jacadv.2025.102208_bib32","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jacc.2025.03.542","article-title":"Early increase in serum transthyretin by acoramidis independently predicts improved survival in TTR amyloid cardiomyopathy","volume":"85","author":"Maurer","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.jacadv.2025.102208_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.11604\/pamj.2019.33.61.18083","article-title":"Predictors of mortality in hemodialysis patients","volume":"33","author":"Msaad","year":"2019","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.jacadv.2025.102208_bib34","first-page":"A15440","article-title":"Abstract 15440: elevated serum transthyretin concentration found to be associated with increased survival rate in hereditary transthyretin cardiomyopathy patients","volume":"146","author":"Nandakumar","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102208_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s12603-015-0626-5","article-title":"The prognostic value of high-sensitivity C-reactive protein and prealbumin for short-term mortality in acutely hospitalized multimorbid elderly patients: a prospective cohort study","volume":"20","author":"Nouvenne","year":"2016","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jacadv.2025.102208_bib36","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.3945\/ajcn.2008.25906","article-title":"Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis","volume":"88","author":"Rambod","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacadv.2025.102208_bib37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3892\/etm.2020.8865","article-title":"Application of blood pre-albumin and NT-pro BNP levels in evaluating prognosis of elderly chronic heart failure patients","volume":"20","author":"Shi","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jacadv.2025.102208_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfm573","article-title":"Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients","volume":"23","author":"Terrier","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jacadv.2025.102208_bib39","article-title":"Predictive value of the serum cystatin C\/Prealbumin ratio in combination with NT-proBNP levels for long-term prognosis in chronic heart failure patients: a retrospective cohort study","volume":"8","author":"Wang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2025.102208_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1186\/s12877-024-05467-3","article-title":"Low transthyretin concentration linked to adverse prognosis in elderly inpatients","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jacadv.2025.102208_bib41","article-title":"Prognostic value of prealbumin, N-terminal pro-B-type natriuretic peptide, heart type fatty acid binding protein, and cardiac troponin I in elderly patients for heart failure and poor outcomes","volume":"49","author":"Wang","year":"2021","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jacadv.2025.102208_bib42","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1159\/000507331","article-title":"Serum prealbumin and echocardiography parameters predict mortality in peritoneal dialysis patients","volume":"45","author":"Ye","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jacadv.2025.102208_bib43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2147\/CIA.S162764","article-title":"Association of prealbumin levels with contrast-induced acute kidney injury in elderly patients with elective percutaneous coronary intervention","volume":"13","author":"You","year":"2018","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.jacadv.2025.102208_bib44","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jchf.2019.04.010","article-title":"Screening for transthyretin amyloid cardiomyopathy in everyday practice","volume":"7","author":"Witteles","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib45","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jcmg.2023.05.002","article-title":"Development and validation of a prediction model and score for transthyretin cardiac amyloidosis diagnosis: T-Amylo","volume":"16","author":"Arana-Achaga","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jacadv.2025.102208_bib46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1745-6215-14-391","article-title":"Response to: practical methods for incorporating summary time-to-event data into meta-analysis","volume":"14","author":"Wang","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.jacadv.2025.102208_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cct.2015.09.002","article-title":"Meta-analysis in clinical trials revisited","volume":"45","author":"DerSimonian","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jacadv.2025.102208_bib48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"10.1016\/j.jacadv.2025.102208_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamacardio.2024.4112","article-title":"Unfolding the link between transthyretin stability and survival","volume":"10","author":"Angueira","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib50","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/ehf2.15143","article-title":"A phenomap of TTR amyloidosis to aid diagnostic screening","volume":"12","author":"Antonopoulos","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib51","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1002\/ehf2.13646","article-title":"'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor","volume":"8","author":"Abdin","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib52","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2025.04.014","article-title":"Serum transthyretin as a biomarker of treatment response in ATTR cardiomyopathy","volume":"85","author":"Regan","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib53","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/cells10071768","article-title":"Transthyretin: from structural stability to osteoarticular and cardiovascular diseases","volume":"10","author":"Wieczorek","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jacadv.2025.102208_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012146","article-title":"Myocardial inflammation in cardiac transthyretin amyloidosis: prevalence and potential prognostic implications","volume":"18","author":"M\u00fcller","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102208_bib55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12883-019-1369-4","article-title":"Inflammatory profiling of patients with familial amyloid polyneuropathy","volume":"19","author":"Azevedo","year":"2019","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jacadv.2025.102208_bib56","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.12659\/MSM.902348","article-title":"Association of serum prealbumin with angiographic severity in patients with acute coronary syndrome","volume":"23","author":"Zhang","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jacadv.2025.102208_bib57","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3429541","article-title":"Plasma proteome profiling of coronary artery disease patients: downregulation of Transthyretin-An important event","volume":"2020","author":"Monu","year":"2020","journal-title":"Med Inflamm"},{"key":"10.1016\/j.jacadv.2025.102208_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179806","article-title":"Predictive value of serum transthyretin for outcome in acute ischemic stroke","volume":"12","author":"Ambrosius","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacadv.2025.102208_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2017.04.015","article-title":"Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus","volume":"470","author":"Wakabayashi","year":"2017","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.jacadv.2025.102208_bib60","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1161\/CIRCULATIONAHA.105.535435","article-title":"Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals","volume":"112","author":"Vlachopoulos","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102208_bib61","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/ijms20092322","article-title":"Inflammatory and molecular pathways in heart failure\u2014ischemia, HFpEF and transthyretin cardiac amyloidosis","volume":"20","author":"Michels da Silva","year":"2019","journal-title":"Intern J Mol Sci"},{"key":"10.1016\/j.jacadv.2025.102208_bib62","doi-asserted-by":"crossref","first-page":"21998","DOI":"10.1074\/jbc.M602302200","article-title":"Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy","volume":"281","author":"Teixeira","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacadv.2025.102208_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30995-5","article-title":"A FTIR microspectroscopy study of the structural and biochemical perturbations induced by natively folded and aggregated transthyretin in HL-1 cardiomyocytes","volume":"8","author":"Ami","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacadv.2025.102208_bib64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/CIRCRESAHA.110.227819","article-title":"Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease","volume":"107","author":"Minamino","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.jacadv.2025.102208_bib65","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/13506129.2025.2486072","article-title":"Computed tomography-derived myocardial radiomics for detection of transthyretin amyloidosis in patients with severe aortic stenosis","volume":"32","author":"Antonopoulos","year":"2025","journal-title":"Amyloid"},{"key":"10.1016\/j.jacadv.2025.102208_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11897-022-00570-1","article-title":"Update on disease-specific biomarkers in transthyretin cardiac amyloidosis","volume":"19","author":"Hood","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacadv.2025.102208_bib67","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jaccao.2021.08.007","article-title":"Effect of tafamidis on serum transthyretin levels in non-trial patients with transthyretin amyloid cardiomyopathy","volume":"3","author":"Falk","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jacadv.2025.102208_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.05.015","article-title":"Transthyretin serum levels and clinical outcomes in patients with transthyretin amyloid cardiomyopathy","author":"Minervini","year":"2025","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacadv.2025.102208_bib69","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/jamacardio.2019.0849","article-title":"Association of patisiran, an RNA interference therapeutic, with regional left ventricular myocardial strain in hereditary transthyretin amyloidosis: the APOLLO study","volume":"4","author":"Minamisawa","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacadv.2025.102208_bib70","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2409134","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","volume":"392","author":"Fontana","year":"2025","journal-title":"N Engl J Med"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25006350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X25006350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:27:17Z","timestamp":1775068037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X25006350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772963X25006350"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102208","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum Transthyretin as Prognostic Biomarker for Cardiovascular Events and Mortality","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102208"}}